Stock Track | Haixi Pharma Soars 21.53% on Hong Kong Trading Debut Following Successful IPO

Stock Track

Oct 20

Haixi Pharma (HKG:02637) experienced a remarkable surge of 21.53% in its stock price during the pre-market trading session on Monday, marking a strong start to its first day of trading on the Hong Kong Stock Exchange. This impressive debut comes on the heels of the company's successful initial public offering (IPO), which raised a substantial HK$940.1 million in net proceeds.

The pharmaceutical company's shares were priced at the top end of the expected range at HK$86.40 per share, reflecting strong investor interest. The Hong Kong public offer portion of the IPO was significantly oversubscribed, with demand exceeding the available shares by 3,165.1 times. Meanwhile, the international offering was 6.3 times oversubscribed, indicating robust global investor appetite for Haixi Pharma's shares.

Adding to the positive sentiment, cornerstone investor Harvest International Premium Value (Secondary Market) Fund SPC, acting on behalf of Harvest Oriental SP, subscribed to 1,981,700 shares, representing 17.23% of the total offer shares. This substantial commitment from a cornerstone investor likely contributed to the strong market debut. As Haixi Pharma begins its journey as a publicly-traded company, investors will be closely watching its performance in the coming days and weeks.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1177343357"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177343357\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177343357?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-20 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177343357","market":"nz","top_or_hot":-1,"title":"Stock Track | Haixi Pharma Soars 21.53% on Hong Kong Trading Debut Following Successful IPO","media":"Stock Track","content":"<p>Haixi Pharma (HKG:02637) experienced a remarkable surge of 21.53% in its stock price during the pre-market trading session on Monday, marking a strong start to its first day of trading on the Hong Kong Stock Exchange. This impressive debut comes on the heels of the company's successful initial public offering (IPO), which raised a substantial HK$940.1 million in net proceeds.</p>\n\n<p>The pharmaceutical company's shares were priced at the top end of the expected range at HK$86.40 per share, reflecting strong investor interest. The Hong Kong public offer portion of the IPO was significantly oversubscribed, with demand exceeding the available shares by 3,165.1 times. Meanwhile, the international offering was 6.3 times oversubscribed, indicating robust global investor appetite for Haixi Pharma's shares.</p>\n\n<p>Adding to the positive sentiment, cornerstone investor Harvest International Premium Value (Secondary Market) Fund SPC, acting on behalf of Harvest Oriental SP, subscribed to 1,981,700 shares, representing 17.23% of the total offer shares. This substantial commitment from a cornerstone investor likely contributed to the strong market debut. As Haixi Pharma begins its journey as a publicly-traded company, investors will be closely watching its performance in the coming days and weeks.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Haixi Pharma Soars 21.53% on Hong Kong Trading Debut Following Successful IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Haixi Pharma Soars 21.53% on Hong Kong Trading Debut Following Successful IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-20 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Haixi Pharma (HKG:02637) experienced a remarkable surge of 21.53% in its stock price during the pre-market trading session on Monday, marking a strong start to its first day of trading on the Hong Kong Stock Exchange. This impressive debut comes on the heels of the company's successful initial public offering (IPO), which raised a substantial HK$940.1 million in net proceeds.</p>\n\n<p>The pharmaceutical company's shares were priced at the top end of the expected range at HK$86.40 per share, reflecting strong investor interest. The Hong Kong public offer portion of the IPO was significantly oversubscribed, with demand exceeding the available shares by 3,165.1 times. Meanwhile, the international offering was 6.3 times oversubscribed, indicating robust global investor appetite for Haixi Pharma's shares.</p>\n\n<p>Adding to the positive sentiment, cornerstone investor Harvest International Premium Value (Secondary Market) Fund SPC, acting on behalf of Harvest Oriental SP, subscribed to 1,981,700 shares, representing 17.23% of the total offer shares. This substantial commitment from a cornerstone investor likely contributed to the strong market debut. As Haixi Pharma begins its journey as a publicly-traded company, investors will be closely watching its performance in the coming days and weeks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02637","symbol_name":"海西新药","start_time":0,"source_url":"","article_id":"1177343357","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177343357","pubTimestamp":1760924003,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Haixi Pharma (HKG:02637) experienced a remarkable surge of 21.53% in its stock price during the pre-market trading session on Monday, marking a strong start to its first day of trading on the Hong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02637":"海西新药"},"translate_title":"个股赛道|成功IPO后海西药业港股首秀大涨21.53%","themeId":"01fb23fb7463438e1609e2def22b10ca","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"Haixi Pharma (HKG:02637) experienced a remarkable surge of 21.53% in its stock price during the pre-market trading session on Monday, marking a strong start to its first day of trading on the Hong Kong Stock Exchange. This impressive debut comes on the heels of the company's successful initial public offering (IPO), which raised a substantial HK$940.1 million in net proceeds.\nThe pharmaceutical company's shares were priced at the top end of the expected range at HK$86.40 per share, reflecting strong investor interest. The Hong Kong public offer portion of the IPO was significantly oversubscribed, with demand exceeding the available shares by 3,165.1 times. Meanwhile, the international offering was 6.3 times oversubscribed, indicating robust global investor appetite for Haixi Pharma's shares.\nAdding to the positive sentiment, cornerstone investor Harvest International Premium Value (Secondary Market) Fund SPC, acting on behalf of Harvest Oriental SP, subscribed to 1,981,700 shares, representing 17.23% of the total offer shares. This substantial commitment from a cornerstone investor likely contributed to the strong market debut. As Haixi Pharma begins its journey as a publicly-traded company, investors will be closely watching its performance in the coming days and weeks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}